Effect of a pharmaceutical care program on vascular risk factors in Type 2 diabetes: the Fremantle diabetes study
Objective: To examine the effect of a 12-month pharmaceutical care (PC) program on vascular risk in type 2 diabetes. Research design and methods: We recruited 198 community-based patients randomized to PC or usual care. PC patients had face-to-face goal-directed medication and lifestyle counseling...
| Main Authors: | , , , |
|---|---|
| Format: | Journal Article |
| Published: |
American Diabetes Association
2005
|
| Online Access: | http://hdl.handle.net/20.500.11937/41001 |
| _version_ | 1848756023254319104 |
|---|---|
| author | Clifford, Rhonda Batty, Kevin Davis, W. Davis, Timothy |
| author_facet | Clifford, Rhonda Batty, Kevin Davis, W. Davis, Timothy |
| author_sort | Clifford, Rhonda |
| building | Curtin Institutional Repository |
| collection | Online Access |
| description | Objective: To examine the effect of a 12-month pharmaceutical care (PC) program on vascular risk in type 2 diabetes. Research design and methods: We recruited 198 community-based patients randomized to PC or usual care. PC patients had face-to-face goal-directed medication and lifestyle counseling at baseline and at 6 and 12 months plus 6-weekly telephone assessments and provision of other educational material. Clinical, biochemical, and medication-related data were sent regularly to each patient’s physician(s). The main outcome measure was change in HbA1c. A diabetes-specific risk engine was used to estimate changes in 10-year coronary heart disease (CHD) and stroke risk in patients without a history of cardiovascular disease. Conclusions: A 12-month PC program in type 2 diabetes reduced glycemia and blood pressure. Pharmacist involvement contributed to improvement in HbA1c independently of pharmacotherapeutic changes. PC could prove a valuable component of community-based multidisciplinary diabetes care. |
| first_indexed | 2025-11-14T09:05:36Z |
| format | Journal Article |
| id | curtin-20.500.11937-41001 |
| institution | Curtin University Malaysia |
| institution_category | Local University |
| last_indexed | 2025-11-14T09:05:36Z |
| publishDate | 2005 |
| publisher | American Diabetes Association |
| recordtype | eprints |
| repository_type | Digital Repository |
| spelling | curtin-20.500.11937-410012017-09-13T16:01:42Z Effect of a pharmaceutical care program on vascular risk factors in Type 2 diabetes: the Fremantle diabetes study Clifford, Rhonda Batty, Kevin Davis, W. Davis, Timothy Objective: To examine the effect of a 12-month pharmaceutical care (PC) program on vascular risk in type 2 diabetes. Research design and methods: We recruited 198 community-based patients randomized to PC or usual care. PC patients had face-to-face goal-directed medication and lifestyle counseling at baseline and at 6 and 12 months plus 6-weekly telephone assessments and provision of other educational material. Clinical, biochemical, and medication-related data were sent regularly to each patient’s physician(s). The main outcome measure was change in HbA1c. A diabetes-specific risk engine was used to estimate changes in 10-year coronary heart disease (CHD) and stroke risk in patients without a history of cardiovascular disease. Conclusions: A 12-month PC program in type 2 diabetes reduced glycemia and blood pressure. Pharmacist involvement contributed to improvement in HbA1c independently of pharmacotherapeutic changes. PC could prove a valuable component of community-based multidisciplinary diabetes care. 2005 Journal Article http://hdl.handle.net/20.500.11937/41001 10.2337/diacare.28.4.771 American Diabetes Association unknown |
| spellingShingle | Clifford, Rhonda Batty, Kevin Davis, W. Davis, Timothy Effect of a pharmaceutical care program on vascular risk factors in Type 2 diabetes: the Fremantle diabetes study |
| title | Effect of a pharmaceutical care program on vascular risk factors in Type 2 diabetes: the Fremantle diabetes study |
| title_full | Effect of a pharmaceutical care program on vascular risk factors in Type 2 diabetes: the Fremantle diabetes study |
| title_fullStr | Effect of a pharmaceutical care program on vascular risk factors in Type 2 diabetes: the Fremantle diabetes study |
| title_full_unstemmed | Effect of a pharmaceutical care program on vascular risk factors in Type 2 diabetes: the Fremantle diabetes study |
| title_short | Effect of a pharmaceutical care program on vascular risk factors in Type 2 diabetes: the Fremantle diabetes study |
| title_sort | effect of a pharmaceutical care program on vascular risk factors in type 2 diabetes: the fremantle diabetes study |
| url | http://hdl.handle.net/20.500.11937/41001 |